Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04780425
Other study ID # KBTH-IRB 100017512020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 26, 2021
Est. completion date June 12, 2021

Study information

Verified date August 2022
Source Korle-Bu Teaching Hospital, Accra, Ghana
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We aim to study the effect of a structured diabetes education program (DESMOND) on diabetes outcomes in a ghanaian population over 3 months


Description:

Protocol summary Background: Health systems in low-income countries are overburdened. Corona virus disease-19 (COVID-19) is a pandemic caused by a novel corona virus, Severe acute respiratory syndrome-corona virus 2 (SARS-CoV2) while diabetes is a long-standing global epidemic. COVID-19 further stresses the already overburdened health systems and Public Health measures to contain COVID-19 have severely disrupted health service delivery, particularly routine care. Delivery of diabetes specific education has traditionally been tied to routine visits and delivered in-person. COVID-19 will likely continue to influence service delivery beyond the pandemic, thus alternative ways of delivering diabetes specific education is needed. Diabetes self-management education is vital to providing diabetes care. It equips patients with critical knowledge and skills for self-care. Recent edicts to stay home in relation to COVID-19 have further heightened the importance of self-care. Appropriate self-management behaviours are associated with lower levels of diabetes related distress, better quality of life and diabetes outcomes overall. Maintaining tight glycaemic control, early in diabetes is associated with fewer microvascular complications and vice versa. Complications of diabetes are prevalent in low resource settings in Africa; partly because of inadequate knowledge on self-care. Diabetes self-management education which is structured and tailor-made for low resource settings may modify self-care behaviors and result in improved self-care, glycaemic control and quality of life. Aim: To compare structured diabetes self-management education with standard of care among adults living with type 2 diabetes Methods: A prospective parallel-group randomised controlled trial with three months follow-up will be conducted in KBTH Polyclinic/Family Medicine Centre and Weija Gbawe Municipal Hospital, two primary care facilities in Accra. Participants will be individually randomised to standard of care or 6 hours of structured diabetes self-management education (DSME) delivered in person on one day . Each arm will have hundred participants. The standard of care arm will receive unstructured DSME as per existing protocols at each study site. The study population will be adults living with diabetes. The primary outcome, mean glycated haemoglobin (HbA1c ) will be measured at three months. Expected outcomes: It is expected that there will be no difference in change in mean glycaemic control, self-efficacy or quality of life at three months between the two arms.


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date June 12, 2021
Est. primary completion date June 9, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Inclusion criteria 1. Self-identified as Ghanaian 2. Ability to speak either English and or Twi 3. be aged > 18 years 4. be receiving treatment at the study site as an out-patient 5. be willing to accept the 6-hour DSME intervention 6. be physically able to participate 7. be primarily responsible for their own care 8. be ambulant at time of recruitment 9. be able to participate in activities in a group setting 10. have permanent residence in Greater Accra Exclusion Criteria: 1. known to have cognitive defects 2. known to have type I diabetes 3. known to be pregnant at the time of recruitment or planning to become pregnant during the study or have given birth less than three months prior to recruitment 4. known to have sickle cell disease 5. Participating in another intervention study at time of recruitment 6. known to have chronic medical complications of diabetes (cardiac, renal, neuropathy, hepatic) or systemic illness at the time of recruitment 7. recruitment of a member of the patients household for this study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
DESMOND
as previously described
Other:
usual care
usual care as per standard treatment guidelines of Ghana unstructured/adhoc diabetes education during clinic visits

Locations

Country Name City State
Ghana Korle Bu Teaching Hospital Accra
Ghana Weija Gbawe Municipal Hospital Accra

Sponsors (3)

Lead Sponsor Collaborator
Korle-Bu Teaching Hospital, Accra, Ghana University of Leicester, Utrecht University

Country where clinical trial is conducted

Ghana, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in mean glaciated heamoglobin (HbA1c) at three months change in glycaemic control 3 months
Secondary Change in mean fasting plasma glucose (FPG) at three months change in fasting plasma glucose 3 months
Secondary Change in mean fasting blood glucose (FBG) at three months change in fasting blood glucose 3 months
Secondary Change in mean blood pressure (BP) at three months change in blood pressure 3 months
Secondary Change in waist circumference (WC) at three months change in waist circumference 3 months
Secondary Change in neck circumference (NC) at three months change in neck circumference 3 months
Secondary Change in body weight (BW) at three months change in body weight 3 months
Secondary Change in problem areas in diabetes (PAID-5) scores Change in diabetes related distress at three months, scored from 0 to 4 for each question. minimum score is 0 maximum score is 20, higher scores mean better outcomes 3 months
Secondary Change in mean summary of diabetes self-care activities (SDSCA) score at three months change in self-efficacy, min score 0 and max score 7 for each question, higher scores mean better outcomes 3 months
Secondary Change in mean WHO quality of life (WHOQoL BREF) score at three months change in quality of life 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2